SureTrader SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Neuralstem Inc. (CUR)

CUR RSS Feed
Add CUR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 1/19/2017 1:33:07 PM - Followers: 181 - Board type: Free - Posts Today: 0

 

Neuralstem Inc. (CUR)

 

 

http://www.neuralstem.com/

 

 

 

Company Information:

Neuralstem, Inc.
9700 Great Seneca Highway
Suite 240
Rockville, MD 20850

301-366-4841

 

CIK:  0001357459

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of central nervous system therapies based on its proprietary human neuronal stem cells and stem-cell derived small molecule compounds. The company?s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical development products include NSI-189, which has completed Phase I clinical trial for the treatment of major depressive disorder, as well as is in Phase I clinical trial for the treatment of other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy; and NSI?566 that has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as is in Phase I clinical trials for the treatment of chronic spinal cord injury and motor deficits due to ischemic stroke. The company was founded in 1996 and is headquartered in Germantown, Maryland.

 

 NeuralStem Inc. Announces First Patient Enrolled In Phase 2 Clinical Trial In Major Depressive Disorder
http://www.biospace.com/News/neuralstem-inc-announces-first-patient-enrolled-in/419306

To follow the  Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder

Link here;
https://clinicaltrials.gov/ct2/show/NCT02695472?term=nsi-189&rank=1

 

Management: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-govmanage

 

 

 

 

 

 

 

INTELLECTUAL PROPERTY

At the heart of  Neuralstem's therapeutic cell development programs is the is ability to isolate and grow human neural stem cells from diverse regions of the developing human brain and spinal cord.
 
This technology is supported by our portfolio of issued and pending patents.  The Company has a very pro active plan for obtaining and protecting it's stem cell Intellectual Property, not just in the United States, but world wide.  In addition to it's stem cell intellectual property, the company has been active in licensing in important intellectual property rights for newly developed devices and equipment that will be required to optimize delivery of  it's stem cell therapeutics through surgical transplantation into the brain and spinal cord.

 

Patents Issued

 Number

Country  

 Filing Date

 Issue Date

 Expiration Date

 Title 

 5,753,506

 US

 09/25/96

 05/19/98

 09/25/2016

Isolation, Propagation, and Directed Differentiation of Stem Cell from Embryonic and Adult Central Nervous System of Mammals 

 6,040,180

 US

 05/07/97

 03/21/00

 09/25/2016

In Vitro Generation of Differentiated Neurons from Cultures of Mammalian Multi-potential CNS Stem Cell

 6,284,539

 US 

 10/09/98

 09/04/01

 10/9/2018

Method for Generating Dopaminergic Cells Derived from Neural Precursors

 755849 

 Australia

 09/22/99 

 04/03/03

 09/20/2019

Stable Neural Stem Cell Lines


Investor Information:
http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-IRHome

Recent News: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-news&nyo=0

 

http://finance.yahoo.com/q/h?s=CUR+Headlines

 

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357459&type=&dateb=&owner=include&count=40

 

Transfer Agent:

American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038

 

Share Structure:

See filings

Common Stock

Authorized 300,000,000 6/30/16
Issued and Outstanding 2016 114,760,960 7/31/16
Issued and Outstanding 2015 92,005,705 6/30/16


Prefered Stock

Authorized 7,000,000 6/30/16
Issued 0 6/30/16
Outstanding 0 6/30/16


 


 

Investor Relations:

Neuralstem, Inc. 
Phone: 301-366-4960 x1
E-mail:
[email protected]

 

 

 

 

 

 



 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

 

Please keep your posts on topic because your message(s) will probably be deleted when:

* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CUR
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#4396   looking for run to 5 or 7.00 easy IHuser 01/19/17 01:33:07 PM
#4395   Neuralstem Inc. New 2017 patent.... http://patft.uspto.gov/netacgi/nph-Parser?S 08190819 01/18/17 03:47:50 PM
#4394   $5.00 near term IMO..let's go IHuser 01/18/17 03:03:58 PM
#4393   After CUR R/S was 0.31, before 4.oo.... 13-1 08190819 01/18/17 02:59:06 PM
#4392   Looks like CUR is ticking up now. crowin 01/18/17 02:55:41 PM
#4391   Guess your watch is broken shanghai_steve 01/18/17 02:23:17 PM
#4390   Fact is that we are now at the s_Henderson 01/18/17 01:35:07 PM
#4389   on watch for afternoon rally..IMO IHuser 01/18/17 01:19:36 PM
#4388   R/S and down massively over the past week shanghai_steve 01/18/17 07:10:34 AM
#4387   I dont think so... this one is going bullish 08190819 01/17/17 11:45:34 PM
#4386   Wow this stock sucks dikc shanghai_steve 01/17/17 07:24:07 PM
#4385   Rally starting here, bottom in IMO IHuser 01/17/17 02:15:11 PM
#4384   Ready to run post-split...IMO IHuser 01/12/17 10:29:34 AM
#4383   NEURALSTEM’s patent-protected technology enables, for the first time, 08190819 01/11/17 09:15:55 PM
#4382   Biotech stocks for your portfolio: Neuralstem, Inc. (CUR), 08190819 01/11/17 12:32:40 PM
#4381   Are the above stats for real? firebase_mohawk 01/11/17 11:26:50 AM
#4380   More than normal pre-market action. crowin 01/11/17 08:11:08 AM
#4379   Greedy me was waiting to pick up more crowin 01/11/17 07:37:02 AM
#4378   Not bashing here, just looking at what's in wiredawg 01/10/17 09:20:18 PM
#4377   Yup. I got out just short of 6.00 Vermicious Knid 01/10/17 08:58:34 PM
#4376   The timing seems shady...to reverse split on Friday, wiredawg 01/10/17 08:43:22 PM
#4375   yeah, look at what happened to ULUR today..up shotgun 01/10/17 07:00:48 PM
#4374   $10.40 for me. I'm condident we will easily s_Henderson 01/10/17 04:51:14 PM
#4373   I need $18 a share to get back shotgun 01/10/17 04:48:15 PM
#4372   CUR 7.05 up a buck AH PAC 01/10/17 04:46:18 PM
#4371   Run CURrest RUN!! Vermicious Knid 01/10/17 03:53:57 PM
#4370   Grate news finally!!!! 08190819 01/10/17 03:33:23 PM
#4369   CUR recevied a patent today! That's where the s_Henderson 01/10/17 03:04:05 PM
#4368   CUR another low float r/s running PAC 01/10/17 02:25:11 PM
#4367   Not quite yet, but hopefully soon ;) s_Henderson 01/10/17 02:12:29 PM
#4366   Going to $10.00!! Vermicious Knid 01/10/17 02:10:23 PM
#4365   Can someone confirm that in terms of volume s_Henderson 01/10/17 02:08:31 PM
#4364   Good to see volume picking up and the s_Henderson 01/10/17 01:52:45 PM
#4363   13 to 1 got us to $4, but CUIN2 01/09/17 09:42:54 PM
#4362   Yes, I finally found the document re May Japes1 01/09/17 01:17:53 PM
#4361   Y'all react to some arsepounding today? shanghai_steve 01/09/17 09:03:13 AM
#4360   I doublechecked and indeed May 30th 2017 is s_Henderson 01/08/17 05:57:55 PM
#4359   I might have missed the filing or the s_Henderson 01/08/17 08:06:20 AM
#4358   I'm curious as to why they did the Japes1 01/08/17 03:21:00 AM
#4357   I agree that a R/S su*ks, but I s_Henderson 01/07/17 07:02:43 AM
#4356   Wow $4 that was back in 2014. crowin 01/06/17 08:04:37 PM
#4355   Omg this pig is done. F&$& should shanghai_steve 01/06/17 06:33:01 PM
#4354   R/S's always suck for long term shareholders IMO. CUIN2 01/06/17 04:28:17 PM
#4353   Yeah...but could be one of those few instances wiredawg 01/06/17 01:51:09 PM
#4352   Neuralstem Announces a 1-for-13 Reverse Stock Split crowin 01/06/17 01:41:15 PM
#4351   Well that's typically a good sign...still though, a wiredawg 12/31/16 12:21:29 AM
#4350   Daley bought another 32,000 shares today. He is tommsel1 12/30/16 11:47:23 PM
#4349   Drug approval for "NSI-189"..will make or break CUR...given wiredawg 12/19/16 03:28:55 PM
#4348   What's the impetus here? Cburg 12/19/16 01:11:05 PM
#4347   great keep moving up! crowin 12/19/16 11:28:37 AM
PostSubject